PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 1, 20260 citationsOpen Access

A Randomized Comparative Clinical Study on the Efficacy of Dadimavaleha as an Adjuvant to Iron-Folic Acid (Ifa) Versus Iron-Folic Acid (Ifa) in the Management of Garbhini Pandu (Anemia in Pregnancy)

View Full Paper
2L2Dr. Pratiksha Rathod *1Samruddhi Lade

Key Points

  • To compare the efficacy of Dadimavaleha as an adjuvant with Iron-Folic Acid in improving haemoglobin levels and alleviating symptoms of Garbhini Pandu.
  • Random allocation of pregnant women with Garbhini Pandu into two groups.
  • Group A received Dadimavaleha with Iron-Folic Acid, while Group B received modified Iron-Folic Acid treatment.
  • Initial evaluations measured haemoglobin and clinical symptoms.
  • Both groups continued treatment for a fixed period and were monitored for improvements.
  • The combined treatment group (Dadimavaleha with Iron-Folic Acid) is expected to show greater improvements in haemoglobin levels.
  • Fewer gastrointestinal complaints are anticipated in the combination group.
  • Symptoms such as weakness and anorexia are expected to reduce more quickly in the group receiving Dadimavaleha.

Abstract

Introduction: Garbhini Pandu, an anaemic state occurring during pregnancy, is described in Ayurveda as a condition marked by fatigue, pallor and reduced strength. In modern terms, it parallels iron-deficiency anaemia, a common maternal health challenge. Iron–Folic Acid (IFA) remains the standard therapy for improving haemoglobin and preventing pregnancy complications. Comparing two IFA regimens can help understand their relative benefits in correcting anaemia and easing symptoms of Garbhini Pandu. This study evaluates their clinical usefulness in pregnant women with this condition. Objectives: To compare the effect of Efficacy of Dadimavaleha as an Adjuvant to Iron Folic Acid in one group and only Iron- Folic Acid in other group on Haemoglobin level. And also compare the clinical symptoms (Pallor, Weakness, and Anorexia) in both groups. Methods: Pregnant women diagnosed with Garbhini Pandu were selected for the study and assigned into two groups through simple random allocation. Group A received the Dadim Avleha with IFA Tablet while Group B was given a modified IFA schedule as designed for the trial. Initial evaluation included haemoglobin and symptoms both groups continued their respective treatments for a fixed period. Improvement in blood parameters and clinical signs was recorded and compared to assess the relative effectiveness of the two regimens. Expected Result: Women receiving the combined treatment of Dadimavaleha with Iron–Folic Acid are expected to show improvement in anaemia than those taking only Iron–Folic Acid. this group may also experience fewer stomach-related complaints, which commonly occur with iron tablets. The combination is likely to produce a better rise in haemoglobin and Symptoms of Garbhini Pandu such as general weakness and Anorexia are expected to reduce more quickly in the combination group because Dadimavaleha supports digestion and enhances nutrient uptake. Conclusion: It will be drawn after obtaining the results of the study.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

2Dr. Pratiksha Rathod *1Samruddhi Lade (2026) studied this question.

synapsesocial.com/papers/69a3d843ec16d51705d2ef58https://doi.org/10.5281/zenodo.18796984
Ask AI
Helpful
Bookmark
Share
View Full Paper